• bitcoinBitcoin(BTC)$64,942.000.92%
  • ethereumEthereum(ETH)$1,822.270.13%
  • tetherTether(USDT)$1.000.00%
  • binancecoinBNB(BNB)$592.040.50%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.972.15%
  • solanaSolana(SOL)$73.753.58%
  • tronTRON(TRX)$0.3063090.47%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.04-1.70%
  • HyperliquidHyperliquid(HYPE)$69.764.88%
  • zcashZcash(ZEC)$955.949.74%
  • moneroMonero(XMR)$509.741.65%
  • dogecoinDogecoin(DOGE)$0.0594251.24%
  • leo-tokenLEO Token(LEO)$9.301.11%
  • USDSUSDS(USDS)$1.000.00%
  • whitebitWhiteBIT Coin(WBT)$62.740.53%
  • chainlinkChainlink(LINK)$9.311.56%
  • cardanoCardano(ADA)$0.1552051.85%
  • stellarStellar(XLM)$0.1400802.05%
  • Ethena USDeEthena USDe(USDE)$1.000.01%
  • daiDai(DAI)$1.00-0.01%
  • bitcoin-cashBitcoin Cash(BCH)$212.182.41%
  • nearNEAR Protocol(NEAR)$3.252.70%
  • RainRain(RAIN)$0.005520-21.41%
  • litecoinLitecoin(LTC)$44.991.31%
  • uniswapUniswap(UNI)$5.435.99%
  • CantonCanton(CC)$0.081899-1.43%
  • avalanche-2Avalanche(AVAX)$7.251.70%
  • tether-goldTether Gold(XAUT)$3,847.23-0.01%
  • suiSui(SUI)$0.742.65%
  • USD1USD1(USD1)$1.00-0.01%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.04-0.38%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • hedera-hashgraphHedera(HBAR)$0.057956-0.14%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.05%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • crypto-com-chainCronos(CRO)$0.0448523.93%
  • BittensorBittensor(TAO)$194.282.85%
  • quant-networkQuant(QNT)$156.580.92%
  • shiba-inuShiba Inu(SHIB)$0.000004-0.18%
  • MemeCoreMemeCore(M)$0.9210.65%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.21%
  • okbOKB(OKB)$86.772.45%
  • aaveAave(AAVE)$113.254.25%
  • pax-goldPAX Gold(PAXG)$3,849.890.01%
  • Falcon USDFalcon USD(USDF)$1.00-0.01%
  • United StablesUnited Stables(U)$1.000.05%
  • pepePepe(PEPE)$0.0000040.68%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Scientists make ibuprofen and other common painkillers from paper industry waste

July 9, 2023
in AI & Technology
Reading Time: 2 mins read
A A
Scientists make ibuprofen and other common painkillers from paper industry waste
ShareShareShareShareShare

It’s probably fair to say that when most people conjure images of the pharmaceutical industry, it’s not often there’s an association between the production of life-saving drugs and environmental decline. But according to one 2019 study by The Conversation, drug companies produce more tonnes of carbon dioxide equivalents per million dollars than the automotive industry. “By our calculations, the pharma market is 28 percent smaller yet 13 percent more polluting than the automotive sector,” the outlet said of the state of the pharmaceutical industry in 2015. Put another way: drug companies need to reduce their carbon emissions for the health of the planet and everyone living on it.

Thankfully, a group of scientists from the University of Bath in the United Kingdom may have found a way for the industry to do exactly that. In a study published in the journal ChemSusChem, the team describes a process they created for converting β-pinene, a component found in turpentine, into pharmaceutical precursors that they then used to synthesize paracetamol and ibuprofen. Right now, most companies producing those painkillers use chemical precursors derived from crude oil. Turpentine, meanwhile, is a waste by-product the paper industry makes at a scale of more than 350,000 metric tonnes per year. The researchers say they also successfully used turpentine to synthesize 4-HAP, a precursor for beta-blockers, the asthma inhaler drug salbutamol and a range of household cleaners.

YOU MAY ALSO LIKE

5 Important Bose Headphone Settings That Need To Be Manually Turned On

The Smartest AI Decision Might Be Not Sending the Message – Unite.AI

In addition to being more sustainable, the team’s “bio-refinery” process could lead to more consistent drug costs for consumers since turpentine isn’t subject to the same geopolitical pressures that can send energy and oil prices skyrocketing. However, a significant pitfall of the process in its current form is that it costs more to produce drugs with turpentine than crude oil. The team suggests consumers may be willing to pay slightly higher prices for more sustainable drugs, but let’s be honest, when someone is sick or in pain, paying more for relief is the last thing most people want to do.

Credit: Source link

ShareTweetSendSharePin

Related Posts

5 Important Bose Headphone Settings That Need To Be Manually Turned On
AI & Technology

5 Important Bose Headphone Settings That Need To Be Manually Turned On

November 17, 2026
The Smartest AI Decision Might Be Not Sending the Message – Unite.AI
AI & Technology

The Smartest AI Decision Might Be Not Sending the Message – Unite.AI

November 17, 2026
Sarvam Launches Sarvam Token Factory: Bringing India-Hosted Inference to 8 Open Models
AI & Technology

Sarvam Launches Sarvam Token Factory: Bringing India-Hosted Inference to 8 Open Models

November 17, 2026
Adam Mosseri Thinks It Will Be ‘Pretty Challenging’ To Design Instagram For The iPhone Duo
AI & Technology

Adam Mosseri Thinks It Will Be ‘Pretty Challenging’ To Design Instagram For The iPhone Duo

November 17, 2026
Next Post
Psychedelics Gaining Acceptance; What Does It Mean For Investors?

Psychedelics Gaining Acceptance; What Does It Mean For Investors?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
FAA Allows Flights To Resume After Hours-Long Ground Stop Across The US

FAA Allows Flights To Resume After Hours-Long Ground Stop Across The US

November 14, 2026
Monthlong housing protest camp cleared in Madrid

Monthlong housing protest camp cleared in Madrid

November 12, 2026
Thrivent Mid Cap Stock Fund Q3 2026 Commentary (TMSIX)

Thrivent Mid Cap Stock Fund Q3 2026 Commentary (TMSIX)

November 17, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!